Caricamento...

Engineering CAR-T Cells for Improved Function Against Solid Tumors

Genetic engineering T cells to create clinically applied chimeric antigen receptor (CAR) T cells has led to improved patient outcomes for some forms of hematopoietic malignancies. While this has inspired the biomedical community to develop similar strategies to treat solid tumor patients, challenges...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Morgan, Michael A., Schambach, Axel
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217729/
https://ncbi.nlm.nih.gov/pubmed/30420856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02493
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !